Vis enkel innførsel

dc.contributor.authorCui, Guanglin
dc.contributor.authorFan, Qingbo
dc.contributor.authorLi, Zhenfeng
dc.contributor.authorGoll, Rasmus
dc.contributor.authorFlorholmen, Jon
dc.date.accessioned2021-09-28T07:50:42Z
dc.date.available2021-09-28T07:50:42Z
dc.date.created2021-05-06T13:53:52Z
dc.date.issued2021
dc.identifier.citationCui, G., Fan, Q., Li, Z., Goll, R. & Florholmen, J. (2021). Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. EBioMedicine, 66: 103329. doi:en_US
dc.identifier.issn2352-3964
dc.identifier.urihttps://hdl.handle.net/11250/2783939
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleEvaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease : Current and novel biomarkersen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 The Author(s)en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Infeksjonsmedisin: 776en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologi: 773en_US
dc.source.pagenumber9en_US
dc.source.volume66en_US
dc.source.journalEBioMedicineen_US
dc.identifier.doi10.1016/j.ebiom.2021.103329
dc.identifier.cristin1908545
dc.relation.projectNorthern Norway Regional Health Authority: SFP-44-04en_US
dc.source.articlenumber103329en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal